This Small-Cap Pharma to Unlock Rs 279 Crore in Cash from Mumbai Property Sale
This Small-Cap Pharma to Unlock Rs 279 Crore in Cash from Mumbai Property Sale
Unichem Laboratories' decision to sell its Mumbai property boosts investor confidence as stock hits day's high of Rs 635.10, up 4.66 per cent. The buyer in this transaction is Macrotech Developers Limited
Unichem Laboratories' decision to sell its Mumbai property boosts investor confidence as stock hits day's high of Rs 635.10, up 4.66 per cent. The buyer in this transaction is Macrotech Developers Limited
Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK
With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.
With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.
Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News
Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.
Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.
US Biosecure Act, China Plus One, and Trump’s Tariff War: CDMOs Are Hot Topic, As This Small-Cap Pharma Gains 2.66% on CDMO Expansion
Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.
Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.
Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent
The company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
Mid-Cap Pharma Stock: Indian Arm of Covid Vaccine Maker Soars 8 per cent
Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals
Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals
Specialty chemicals & pharma company incorporated a new subsidiary for business expansion!
The stock gave multibagger returns of over 200 per cent from its 52-week low of Rs 58.20 per share.
The stock gave multibagger returns of over 200 per cent from its 52-week low of Rs 58.20 per share.
Mukul Agrawal and Vijay Kedia Gains Rs 6.71 Crore and Rs 19.19 Crore as Stock Hits Upper Circuit Today: Stock Rallies Over 900 Per cent in Just 2 Years!
The company’s shares have delivered a multibagger return of over 200 per cent in the past 1 year.
The company’s shares have delivered a multibagger return of over 200 per cent in the past 1 year.
3:1 Bonus Share & FIIs took a fresh entry in this low PE, high ROE & high ROCE multibagger pharma stock under Rs 80; PAT zooms over 500 per cent
The stock gave multibagger returns of 1,460 per cent in 2 years, 2,300 per cent in 3 years and a whopping 14,200 per cent in 5 years.
The stock gave multibagger returns of 1,460 per cent in 2 years, 2,300 per cent in 3 years and a whopping 14,200 per cent in 5 years.
Penny Stock Under Rs 5: Don't Miss Out on the Micro-Cap's Major News!
This groundbreaking technology has the potential for eliminating the need for painful injections.
Transgene Biotek Ltd.'s partnership with NiedlFree Technologies has the potential to revolutionize the way people with diabetes manage their condition. Oral insulin delivery could eliminate the need for painful injections and make it easier for people to adhere to their treatment plans. This could lead to improved health outcomes and a better quality of life for millions of people worldwide.
Is The Pharmaceutical Industry Shaping Up To Be The New IT?
US Drug Shortages and India’s Competitive Advantage
Given the shared traits between the pharmaceutical and IT industries,
Special Feature On Pharmaceutical & Healthcare Industry
Keeping Good Health
The corona virus pandemic drew everyone's attention to the need for basic medical facilities across the country, elevating the pharmaceutical and healthcare industries and compelling the government to pay greater attention to them. Mandar Wagh describes how being a major participant in terms of both volume and value globally, the government's emphasis and initiatives all contribute to the success of the industry